Overview
Endovascular Advances: A Hands-on Preceptorship Program
Registration is closed for this activity.
This series is designed to provide physicians with hands-on training in all aspects of managing peripheral arterial disease and AV access, including both diagnosis and treatment. Approved attendees will be trained for a two-day program under the direct supervision of the program faculty at the program site. Attendees can expect to gain exposure to atherectomy, CTO crossing strategies, stenting, and AV access to address the ongoing educational needs of the intended audience.
This activity is intended for vascular surgeons, interventional cardiologists, and interventional radiologists looking to expand their hands-on experience in the treatment of peripheral arterial disease and AV access.
This series is designed to provide physicians with hands-on training in all aspects of managing peripheral arterial disease and AV access, including both diagnosis and treatment. Approved attendees will be trained for a two-day program under the direct supervision of the program faculty at the program site. Attendees can expect to gain exposure to atherectomy, CTO crossing strategies, stenting, and AV access to address the ongoing educational needs of the intended audience.
Upon completion of this activity, participants will be able to:
Peripheral Arterial Disease
• Analyze risk assessment and diagnostic methods in peripheral arterial disease
• Compare and contrast medical, surgical, and endovascular treatment options for peripheral arterial disease
• Formulate strategies to manage potential complications
• Evaluate various CLI treatment strategies including: vessel preparation with atherectomy, drug elution therapies
Carotid
• Analyze risk assessment and diagnostic methods in carotid artery disease
• Compare and contrast medical, surgical, and endovascular treatment options for carotid artery disease
• Formulate strategies to manage potential complications
AV Access - Dr. Ross
• Evaluate devices for maintaining access in patients with renal disease
• Perform arteriovenous fistula and graft surgeries and ensure maintenance
• Demonstrate endovascular thrombectomy techniques
• Evaluate and create proper dialysis access and patient management
Topics Include
- Atherectomy
- CTO crossing strategies
- Stenting
- AV access
- Atherectomy
- CTO crossing strategies
- Stenting
- AV access
Supported by an educational grant from Boston Scientific Corporation
INVITED FACULTY
Rajesh Dave, MD, FACC
Holy Spirit Hospital
Camp Hill, PA
Steve Henao, MD, FACC
Heart Hospital of New Mexico
at Lovelace Medical Center
Albuquerque, NM
James Joye, DO, FACC
Silicon Valley Interventional Center
Mountain View, CA
Michael Silva Jr., MD, FACS
The University of Texas
Medical Branch
Galveston, TX
John Ross, MD, FACS
The Regional Medical Center
(Dialysis Access Institute)
Orangeburg, SC
Rajesh Dave, MD, FACC
Holy Spirit Hospital
Camp Hill, PA
Steve Henao, MD, FACC
Heart Hospital of New Mexico
at Lovelace Medical Center
Albuquerque, NM
James Joye, DO, FACC
Silicon Valley Interventional Center
Mountain View, CA
Michael Silva Jr., MD, FACS
The University of Texas
Medical Branch
Galveston, TX
John Ross, MD, FACS
The Regional Medical Center
(Dialysis Access Institute)
Orangeburg, SC
The Academy for Continued Healthcare Learning (ACHL) requires that the faculty participating in a CME activity disclose all affiliations or other financial relationships (1) with the manufacturers of any commercial product(s) and/or provider(s) of commercial services discussed in an educational presentation and (2) with any commercial supporters of the activity. All conflicts of interest have been resolved prior to this CME activity.
The following financial relationships have been provided:
John Ross, MD
Consulting Agreements: Bard, W. L. Gore & Associates, Inc., LeMaitre
Steve Henao, MD
Nothing to disclose.
Discussion of Off-Label, Investigational, or Experimental Drug/Device Use: None
ACHL staff members and others involved with the planning, development, and review of the content for this activity have no relevant affiliations or financial relationships to disclose.
The content for this activity was developed independently of the commercial supporter. All materials are included with permission. The opinions expressed are those of the faculty and are not to be construed as those of the publisher or grantor.
This educational activity was planned and produced in accordance with the ACCME Accreditation Criteria, Policies, and Standards for Commercial Support. Recommendations involving clinical medicine in a continuing medical education (CME) activity must be based on evidence that is accepted within the profession of medicine as adequate justification for their indications and contraindications in the care of patients. All scientific research referred to, reported, or used in CME in support or justification of a patient care recommendation must conform to the generally accepted standards of experimental design, data collection, and analysis.
This CME activity might describe the off-label, investigational, or experimental use of medications and/or devices that may exceed their FDA-approved labeling. Physicians should consult the current manufacturers’ prescribing information for these products. ACHL requires the speaker to disclose that a product is not labeled for the use under discussion.
To receive credit, participants are required to complete the online pretest, participate in the live activity, and complete the evaluation sent via email following the meeting. Once the evaluation is completed, a certificate will be immediately available and also emailed. There is no fee to participate in the activity or for the generation of the certificate.
Inquiries may be directed to ACHL at (877) 444-8435, ext. 228.
The Academy for Continued Healthcare Learning is accredited by the Accreditation Council for Continuing Medical Education (ACCME) to provide continuing medical education for physicians.
The Academy for Continued Healthcare Learning designates this live activity for a maximum of 19 AMA PRA Category 1 Credits™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.
The Academy for Continued Healthcare Learning designates this live activity for a maximum of 19 AMA PRA Category 1 Credits™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.
